Infectious Diseases Search
Infectious Diseases Infectious Diseases

Conference Reports

22nd International AIDS Conference (AIDS 2018)
Amsterdam, the Netherlands
23 July 2018 - 27 July 2018
American Thoracic Society International Conference 2018 (ATS 2018)
San Diego, California, US
18 May 2018 - 23 May 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018)
Madrid, Spain
21 April 2018 - 24 April 2018
National-Dengue-and-Arbovirus-Infection-Conference-2017
Kuala Lumpur, Malaysia
12 August 2017 - 13 August 2017
15th Urological Association of Asia Congress (UAA 2017)
04 August 2017 - 06 August 2017
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Shanghai, China
15 February 2017 - 19 February 2017
49th Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) 2016
Athens, Greece
25 May 2016 - 28 May 2016
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Patients who recovered from HBV infection still at risk for liver cancer
Dr. Joseph Delano Fule Robles, 05 Dec 2017

Results of a study conducted by the Chinese University of Hong Kong (CUHK) revealed that patients who recovered from hepatitis B virus (HBV) infection are still at risk for hepatocellular carcinoma (HCC). 
HIV incidence rising in young men, MSM of colour
30 Mar 2018
A US study suggests that expanding HIV screening to reduce undiagnosed infections and increasing access to care and treatment to achieve viral suppression are important to lessen HIV transmission. It is also imperative that prevention methods, such as condoms and pre-exposure prophylaxis, be easily accessed, particularly among young men who have sex with men (MSM) and MSM of colour.
NIH, IMU collaboration to boost research, have health impact on Malaysians
Saras Ramiya, 5 days ago
The National Institutes of Health (NIH) and International Medical University (IMU) strengthens their research collaboration with the recent signing of a Memorandum of Understanding (MoU).
Tenofovir alafenamide as good as tenofovir disoproxil fumarate for chronic HBV
27 Jan 2018
In patients with chronic hepatitis B virus (HBV) infection, tenofovir alafenamide (TAF) shows comparable 96-week efficacy and improved renal and bone safety with tenofovir disoproxil fumarate (TDF), a recent study has shown.